About Thiola ® (tiopronin) Thiola (tiopronin) tablets are indicated for the prevention of cystine (kidney) stone formation in patients with severe homozygous cystinuria with urinary cystine >500 ...

During his time at the firm from 2011 to his resignation in October last year, it acquired the rights to sell Thiola, which is used to treat cystinuria. Sufferers may take the drug for life ...

Only last year, hardly anyone noticed. In 2014, Shkreli bumped up the price of a drug called Thiola by 2,000%, from $1.50 a pill to $30. Back then, he was the chief executive officer of a company ...

Travere Therapeutics specializes in rare kidney and metabolic disease treatments with key drugs Filspari and Thiola. Filspari, a key asset for IgA Nephropathy, has received full FDA approval ...

Financial terms of the agreement were not immediately disclosed. Thiola® is approved by the U.S. Food and Drug Administration for the treatment of cystinuria, a rare genetic cystine transport ...

oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the ...

FDA clearance of Retrophin Inc.'s enteric-coated (EC) version of Thiola (tiopronin) 100-mg and 300-mg tablets for cystinuria – a rare, inherited disorder that causes levels of cystine to build up in ...

The first authorized generic version of Thiola ® (tiopronin; Mission Pharmacal Company) has been made available by Teva Pharmaceuticals. Tiopronin is a reducing and complexing thiol indicated ...

Travere’s commercial portfolio also comprises Thiola EC/Thiola which is approved for cystinuria. Moreover, Travere’s clinical-stage pipeline has another late-stage candidate, being developed ...

MALVERN, Pa., July 15, 2024 /CNW/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC ®. "We're proud ...

Endo, Inc., a diversified specialty pharmaceutical company, announced the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' Thiola EC. "We're proud to provide ...